[Federal Register Volume 76, Number 72 (Thursday, April 14, 2011)]
[Notices]
[Pages 20993-20994]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-9077]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Health Resources and Services Administration 
(HRSA) publishes abstracts of information collection requests under 
review by the Office of Management and Budget (OMB), in compliance with 
the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request 
a copy of the clearance requests submitted to OMB for review, e-mail 
[email protected] or call the HRSA Reports Clearance Office on (301) 
443-1129.
    The following request has been submitted to the Office of 
Management and Budget for review under the Paperwork Reduction Act of 
1995:

Proposed Project: Sickle Cell Disease Program Evaluations and Quality 
Improvement Activities--[NEW]

    The Sickle Cell Disease and Newborn Screening Program (SCDNBSP) and 
the Sickle Cell Disease Treatment Demonstration Program (SCDTDP) are 
both administered by the Genetic Services Branch (GSB) of the Division 
of Services for Children with Special Health Needs in the Health 
Resources and Services Administration's (HRSA) Maternal and Child 
Health Bureau (MCHB). The SCDTDP is comprised of geographically 
distributed regional networks that provide coordinated, comprehensive, 
culturally competent, and family-centered care to families with sickle 
cell disease and a national coordinating center to support grantee 
activities. The SCDTDP is designed to improve access to services for 
individuals with sickle cell disease, improve/expand patient and 
provider education, and improve/expand the continuity and coordination 
of service delivery for individuals with sickle cell disease and 
carriers of the sickle cell gene mutation. The SCDNBSP is comprised of 
several national funded community-based sickle cell disease networks 
located in the U.S. and the National Coordinating and Evaluation 
Center. The community-based sickle cell disease networks partner with 
State newborn screening programs, comprehensive sickle cell treatment 
centers, and health care professionals to provide support to infants 
screened positive for sickle cell disease, carriers of the sickle cell 
gene mutation and their families.
    HRSA seeks to conduct two evaluations (SCDTDP evaluation previously 
approved by OMB) and a quality improvement project, the purpose of 
which are to assess the service delivery processes and outcomes 
resulting from the systems of care delivered by the SCDNBSP and SCDTDP 
networks to individuals affected by sickle cell disease who present at 
their sites for care. The clients of the three programs will be the 
respondents for this data collection activity.
    The annual estimate of burden for both the SCDNBSP and the SCDTDP 
evaluations and quality improvement effort is as follows:

                                                  Estimated Hour and Cost Burden of the Data Collection
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                             Number of     Responses per       Total       Average hours    Total hour                      Total hour
             Questionnaires                 respondents     respondent       responses     per response       burden         Wage rate         cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
MDP SCD Questionnaire...................             140               2             280             .45             126          $20.90         $2633.4
MDP SCT Questionnaire...................            1400               1            1400             .30             420           20.90            8778
Utilization Questionnaire (pre-                      900               1             900             .75             675           20.90        14,107.5
 demonstration).........................

[[Page 20994]]

 
Utilization Questionnaire (post                      900               1             900             .50             450           20.90           9,405
 demonstration).........................
SF-36 Health Survey for adults over 18               630               2            1260             .25             315           20.90         6,583.5
 years of age...........................
PedsQL for parents of children &                     270               2             540             .25             135           20.90         2,821.5
 adolescents 18 years or younger........
PedsQL for children & adolescents 18                 225               2             450             .25           112.5           20.90        2,351.25
 years or younger.......................
The Medical Home Family Index (Health                900               2            1800             .25             450           20.90           9,405
 Care Satisfaction).....................
QI Instrument...........................               9              12             108            4                432           20.90        9,028.80
Hemoglobinopathies Emerging Populations              900               2            1800             .20             360           20.90           7,524
 Form...................................
(Client Family Communication)...........
                                         ---------------------------------------------------------------------------------------------------------------
    Total...............................           6,274  ..............           9,438  ..............         3,475.5  ..............       72,637.95
--------------------------------------------------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent within 30 days of this notice to 
the desk officer for HRSA, either by e-mail to [email protected] or by fax to 202-395-6974. Please direct all 
correspondence to the ``attention of the desk officer for HRSA.''

    Dated: April 8, 2011.
Reva Harris,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2011-9077 Filed 4-13-11; 8:45 am]
BILLING CODE 4165-15-P